Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma

Oncogene

Volumn 12, Issue 8, 1996, Pages 1617-1623

  Mujoo, Kalpana ^a   Maneval, Daniel C ^b   Anderson, Scott C ^b   Gutterman, Jordan U ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adenoviral constructs; Gene therapy; p53; Tumorigenicity

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P53;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INFECTION SENSITIVITY; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; VIRUS RECOMBINANT;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; CARCINOGENICITY TESTS; FEMALE; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; OVARIAN NEOPLASMS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029960147     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bacchetti S and Graham FL. (1993). Int. J. Oncology, 3, 781-788.
2. Baker SJ, Markowitz S, Fearon ER, Willson JK and Vogelstein B. (1990). Science, 249, 912-915.
3. Bartek J and Bartkova, J. (1991). Oncogene, 6, 1699-1703.
4. Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J and Bast RC, Jr. (1994). Am. J. Obstet. Gynecol., 170, 246-252.
5. Boente MP, Hurteau J, Rodriguez GC, Bast RC Jr and Berchuck A. (1993). Cur. Opin. Oncol., 5, 900-907.
6. Bosari S, Viale G, Radaelli U, Bossi P, Bonoldi E and Coggi G. (1993). Hum. Pathol., 24, 1175-1179.
7. Brody SL and Crystal RG. (1994). Ann. New York Acad. Sci., 716, 90-103.
8. Casey G, Lo-Hsueh M, Lopez ME, Vogelstein B and Stanbridge EJ. (1991). Oncogene, 6, 1791-1797.
9. Chen PL, Chen Y, Bookstein R and Lee WH. (1990). Science, 250, 1576-1580.
10. Chen Y, Chang P-L, Arnaiz N, Goodrich D and Lee W-H. (1991). Oncogene, 6, 1799-1805.
11. Cheng J, Yee JK, Yeargin J, Friedmann T and Haas M. (1992). Cancer Res., 55, 222-226.
12. Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL and Liu TJ. (1995). Cancer Res., 55, 1-6.
13. Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, Pernis B, Wold WSM, Chanock RM and Prince GA. (1989). Proc. Natl. Acad. Sci. USA, 86, 3823-3827.
14. Gooding LR and Wold WSM. (1990). Crit. Rev. Immunol., 10, 53-71.
15. Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T and Blankenstein T. (1992). Proc. Nad. Acad. Sci. USA, 90, 2774-2775.
16. Hollstein M, Sidransky D, Vogelstein B and Harris C. (1991). Science, 253, 49-53.
17. Isaacs WB, Carter BS and Ewing CM. (1991). Cancer Res., 51, 4716-4720.
18. Jacobs IJ, Kohler MF, Wisemand RW, Marks JR, Kerns BA, Humphrey P, Berchuck A, Ponder BA and Bast RC, Jr. (1992). J. Natl. Cancer Inst., 84, 1793-1798.
19. Johnson P, Grey D, Mowat and Benchimol S. (1991). Mol. Cell. Biol., 11, 1-11.
20. Keurbitz SJ, Plunkett BS, Walsh WV and Kastan NB. (1992). Proc. Natl. Acad. Sci. USA, 9, 7491-7495.
21. Kohler MF, Kerns BJ, Humphreys PA, Marks JR and Bast RC, Jr. (1993). Obstet. Gynecol., 81, 643-650.
22. Lane DP. (1992). Nature, 15-16.
23. Levine AJ, Momand J and Finlay CA. (1991). Nature, 351, 453-456.
24. Liu TJ, Zhang WW, Taylor DL, Roth RJ, Goepfert H and dayman JL. (1994). Cancer Res., 54, 3662-3667.
25. Okamato A, Sameshima Y, Yokoyama S, Terashima Y, Sugimusa T, Terada M and Yokota J. (1991). Cancer Res., 51, 5171-5176.
26. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S and White E. (1992). Proc. Natl. Acad. Sci. USA, 89, 7742-7746.
27. Roemer K and Friedman T. (1994). Ann. New York Acad. Sci., 716, 265-282.
28. Sanes JR, Rubenstein JL and Nicholas JF. (1986). EMBO. J., 5, 3133-3142.
29. Sarnow P, Ho YS, Williams J and Levine AJ. (1982). Cell, 28, 387-394.
30. Shaw P, Bovey R, Tardy S, Sahli R, Sondat B and Costa J. (1992). Proc. Natl. Acad. Sci. USA, 89, 4495-4499.
31. Siegfried W. (1993). Exp. Clin. Endocrinol., 101, 7-11.
32. Takahashi T, Carbone D, Nau MM, Hida T, Linnoila I, Ueda R and Minna JD. (1992). Cancer Res., 52, 2340-2343.
33. Wang NP, To H, Lee WH and Lee EY. (1993). Oncogene, 8, 279-288.
34. Weinberg RA. (1992). Science, 254, 1138-1145.
35. White E, Sabbatini P, Debbas M, Wold WS, Kusher DI and Gooding LR. (1992). Mol. Cell. Biol., 12, 2570-2580.
36. Wingo PA, Tong T and Bolden S. (1995). CA Cancer J. Clin., 45, 8-30.
37. Wills KN, Maneval DC, Menzel P, Harris MP, Sutjipto S, Vaillancourt MT, Huang WM, Johnson DE, Anderson SC and Wen SF. (1994). Hum. Gene Ther., 5, 1079-1088.
38. Yaginuma Y and Westphal H. (1992). Cancer Res., 52, 4196-4199.
39. Zhang WW, Fang X, Mazur W, French BA, Georges RN and Roth JA. (1994). Cancer Gene Therapy, 1, 1-10.